Long-term tolerability of benazepril in dogs with congestive heart failure

Journal of Veterinary Cardiology

Volumn 6, Issue 1, 2004, Pages 7-13

  Pouchelon, Jean Louis ^a   King, Jonathan ^a   Martignoni, Laure ^a   Chetboul, Valérie ^a   Lugardon, Béatrice ^a   Rousselot, Jean François ^a   Corlouer, Jean Philippe ^a   Bussadori, Claudio ^a   Piette, Marie Hélène ^a   Brownlie, Serena ^a   Martel, Philippe ^a   Garcin, Jean Pierre ^a   Hagen, Andreas ^a   Amberger, Christophe ^a   Martin, Michael ^a   Labadie, Fabrice ^a   Collet, Michel ^a   Drouard, Christine ^a   Lombard, Christophe ^a   Hervé, Daniel ^a   Strehlau, Günther ^a   more..

^a NONE

Author keywords

Benazepril; Congestive heart failure; Dogs

Indexed keywords

EID: 8344280959     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1760-2734(06)70059-5     Document Type: Article

References (17)

1. The BENCH Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1 (1999) 7-18
2. Webb R., Miller D., Traina V., et al. Benazepril. Cardiovasc Drug Rev 8 (1990) 89-104
3. King J., Mauron C., and Kaiser G. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administration to dogs. Am J Vet Res 56 (1995) 1620-1628
4. Weinberg M. Renal effects of angiotensin converting enzyme inhibitors in heart failure: A clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances. Clin Therap 15 (1993) 3-17
5. Knight E., Glynn R., McIntyre K., et al. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: Results from the studies of left ventricular dysfunction (SOLVD). Am Heart J 138 (1999) 849-855
6. Garcia N., Baigorria S., and Juncos L. Hyperkalemia, renal failure, and converting-enzyme inhibition an overrated connection. Hypertension 38 (2001) 639-644
7. Roudebusch P., Allen T., Kuehn N., et al. The effect of combined therapy with captopril, furosemide, and a sodiumrestricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure. J Vet Intern Med 8 (1994) 337-342
8. Kitagawa H., Wakamiya H., Kitoh K., et al. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired mitral insufficiency. J Vet Med Sci 59 (1997) 513-520
9. Atkins C., Brown W., Coats J., et al. Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. J Am Vet Med Assoc 221 (2002) 654-658
10. Lefebvre H., Laroute V., Concordet D., et al. Effects of renal impairment on the disposition of orally administered enalapril, benazepril, and their active metabolites. J Vet Intern Med 13 (1999) 21-27
11. The COVE Study Group. Controlled clinical evaluation of enalapril in dogs with heart failure: Results of the Cooperative Veterinary Enalapril Study Group. J Vet Intern Med 9 (1995) 243-252
12. The IMPROVE Study Group. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enapril Study. J Vet Intern Med 9 (1995) 234-242
13. Ettinger S., Benitz A., Ericsson G., et al., for the LIVE Study Group. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. J Am Vet Med Assoc 11 (1999) 1573-1577
14. Kvart C., Haggstrom J., Pederson H., et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 16 (2002) 80-88
15. Brands M., Magdalena A., Mizelle H., et al. Chronic angiotensin-converting-enzyme inhibition improves cardiac output and fluid balance during heart failure. Am J Physiol 264 (1993) 414-422
16. Levens N. Renal actions of the new angiotensin-converting enzyme inhibitor Benazepril Hydrochloride. Arch int Pharmacodyn 296 (1988) 131-143
17. Brown S., Brown C., Jacobs G., et al. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. Am J Vet Res 62 (2001) 375-383